{"id":"W3166204225","doi":"10.1200/jco.21.00972","title":"Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; University of Alberta; University of Calgary","funders":"","keywords":"Ixazomib; Lenalidomide; Medicine; Placebo; Hazard ratio; Internal medicine; Multiple myeloma; Population; Surgery; Gastroenterology; Oncology; Confidence interval; Pathology; Carfilzomib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00215131,0.0008383995,0.001421088,0.0002240862,0.0002356637,0.0006299036,0.0004062111,0.0004735421,0.002049344],"category_scores_gemma":[0.001149028,0.0002339147,0.001478555,0.0001864559,0.0004757936,0.0002267014,0.0003121858,0.001190666,0.0001882189],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007576806,"about_ca_system_score_gemma":0.0008949037,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000868897,"about_ca_topic_score_gemma":0.003521713,"domain_scores_codex":[0.9992569,0.0005193009,0.00002250221,0.00008398919,0.00004953302,0.00006771078],"domain_scores_gemma":[0.9994189,0.0001521602,0.0001477399,0.00004136816,0.00003000893,0.0002099196],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9280938,0.002453083,0.009552824,0.0007289252,0.003031445,0.00005143527,0.00007974493,0.002033371,0.01014013,0.0001576362,0.002124556,0.04155307],"study_design_scores_gemma":[0.691162,0.2214596,0.07131337,0.0001135271,0.004642459,0.0001606966,0.00005113075,0.002548788,0.004210233,0.0004252543,0.003870962,0.00004199407],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9879817,0.006240608,0.0006267396,0.0006023506,0.0001277361,0.0009056019,0.001802109,0.00005678074,0.001656245],"genre_scores_gemma":[0.993758,0.001195348,0.0007429647,0.0003396207,0.0001376029,0.0005834081,0.001752671,0.00001122069,0.001479209],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00215131,"threshold_uncertainty_score":0.01137733,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1482360511515353,"score_gpt":0.462971200887676,"score_spread":0.3147351497361407,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}